| Literature DB >> 21603646 |
Junko Takahashi1, Masaki Misawa, Hitoshi Iwahashi.
Abstract
Miniature pigs are useful model animals for humans because they have similar anatomy and digestive physiology to humans and are easy to breed and handle. In this study, whole blood microarray analyses were conducted to evaluate variations of correlation among individuals and ages using specific pathogen-free (SPF) Clawn miniature pigs. Whole blood RNA is easy to handle compared to isolated white blood cell RNA and can be used for health and disease monitoring and animal control. In addition, whole blood is a heterogeneous mixture of subpopulation cells. Once a great change occurs in composition and expressing condition of subpopulations, their associated change will be reflected on whole blood RNA. From 12 to 30 weeks of age, fractions of lymphocytes, monocytes, neutrophils, eosinophils, and basophils in white blood cells showed insignificant differences with age as a result of ANOVA analysis. This study attempted to identify characteristics of age-related gene expression by taking into account the change in the number of expressed genes by age and similarities of gene expression intensity between individuals. As a result, the number of expressed genes was less in fetal stage and infancy period but increased with age, reaching a steady state of gene expression after 20 weeks of age. Variation in gene expression intensity within the same age was great in fetal stage and infancy period, but converged with age. The variation between 20 and 30 weeks of age was comparable to that among 30 weeks individuals. These results indicate that uniformity of laboratory animals is expected for miniature pigs after 20 weeks of age. Furthermore, a possibility was shown that whole blood RNA analysis is applicable to evaluation of physiological state.Entities:
Mesh:
Year: 2011 PMID: 21603646 PMCID: PMC3094450 DOI: 10.1371/journal.pone.0019761
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Subject body weight results.
| Sex | n | 12 weeks | 16 weeks | 20 weeks | 24 weeks | 30 weeks |
|
| Male | 5 | 7.0±0.6 | 10.7±3.8 | 12.1±2.6 | 15.0±1.7 | 17.7±1.7 | <0.001 |
| Female | 5 | 6.9±0.5 | 7.9±3.2 | 10.1±2.6 | 13.5±2.1 | 16.0±2.6 | <0.001 |
Values are mean±SD.
†P values were calculated using one-way factorial ANOVA.
Subject hematology results.
| Hematological analysis | Sex | n | 12 weeks | 16 weeks | 20 weeks | 24 weeks | 30 weeks |
|
|
| Male | 5 | 742.7±72.6 | 858.0±97.7 | 894.8±55.8 | 919.0±21.0 | 866.2±24.5 | <.05 |
| Female | 5 | 727.0±20.2 | 886.6±62.2 | 921.2±64.5 | 901.4±46.1 | 838.4±44.2 | <.001 | |
|
| Male | 5 | 14.9±1.6 | 16.4±1.2 | 17.3±0.6 | 18.3±0.4 | 17.7±0.3 | <.001 |
| Female | 5 | 14.9±0.4 | 17.5±0.8 | 18.0±0.9 | 18.4±1.1 | 17.5±0.6 | <.001 | |
|
| Male | 5 | 50.9±5.1 | 53.6±2.7 | 54.7±2.1 | 58.4±2.8 | 55.3±1.2 | <.05 |
| Female | 5 | 49.0±1.8 | 56.1±2.2 | 57.8±4.2 | 57.9±3.0 | 54.8±2.8 | <.01 | |
|
| Male | 5 | 65.8±1.0 | 66.3±2.5 | 67.3±2.9 | 65.1±1.4 | 65.8±2.2 | NS |
|
| Male | 5 | 19.8±0.5 | 20.0±1.1 | 20.1±0.9 | 20.5±0.6 | 20.6±0.8 | NS |
|
| Male | 5 | 30.1±0.4 | 30.2±1.0 | 29.9±0.9 | 31.5±0.9 | 31.2±0.8 | NS |
|
| Male | 5 | 21.3±0.4 | 31.6±10.8 | 18.1±4.4 | 25.0±8.6 | 24.9±5.1 | NS |
| Female | 5 | 34.5±2.0 | 24.8±5.5 | 19.0±5.0 | 24.8±8.9 | 19.7±5.7 | <.05 | |
|
| Male | 5 | 13.8±3.2 | 15.5±0.3 | 16.5±0.9 | 15.9±0.7 | 16.1±0.6 | NS |
| Female | 5 | - | 15.8±1.1 | 16.1±0.5 | 16.4±0.5 | 16.0±0.7 | NS | |
|
| Male | 5 | <20 | <20 | <20 | <20 | <20 | |
| Female | 5 | <20 | <20 | <20 | <20 | <20 | ||
|
| Male | 5 | 171.3±36.9 | 185.8±93.8 | 169.4±39.4 | 158.6±9.0 | 147.8±34.2 | NS |
| Female | 5 | - | 160.2±19.4 | 145.2±16.3 | 176.5±20.1 | 123.3±27.5 | <.05 | |
|
| Male | 5 | 62.0±18.7 | 86.6±12.7 | 78.8±24.7 | 79.6±24.0 | 71.8±13.2 | NS |
| Female | 5 | 66.0±23.4 | 74.0±13.7 | 78.0±18.7 | 72.4±10.4 | 61.8±11.3 | NS | |
|
| Male | 5 | 34.8±12.1 | 45.2±7.4 | 44.6±9.3 | 36.8±6.9 | 33.6±7.6 | NS |
|
| Male | 5 | 55.0±10.9 | 43.1±10.3 | 44.8±7.4 | 52.2±7.0 | 56.2±9.2 | NS |
|
| Male | 5 | 3.8±2.2 | 3.1±1.4 | 3.0±1.9 | 5.0±2.7 | 4.6±1.7 | NS |
|
| Male | 5 | 0.3±0.5 | 0.3±0.4 | 0.2±0.4 | 0.0±0.0 | 0.2±0.4 | NS |
|
| Male | 5 | 6.3±1.0 | 8.0±3.2 | 7.4±1.5 | 6.0±2.1 | 5.4±1.3 | NS |
Biochemical variables for miniature pigs during the experiment are shown. Values are mean±SD. RBC, red blood cell count; HGB, hemoglobin concentration; HCT, hematocrit value; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PLT, blood platelet count; PT, prothrombin time; ATPP, activated partial thromboplastin time; Fbg, fibrinogen level; WBC, white blood cell count; and NS: not significant.
†P values were calculated using one-way factorial ANOVA.
Figure 1Number of genes expressed in whole blood of miniature pigs at different ages.
In the graph, ♦ represents male and ▪ represents female. Values are means±SD.
Figure 2Correlation matrix of age-related gene expression.
This color-coded correlation matrix illustrates pairwise correlations between the levels of gene expression in individuals. Probe sets with normalized signals (log-transformed and scaled) were used to calculate correlations between 31 arrays using Pearson correlation coefficient; signals flagged as “absent” were excluded.
Summary of age-related correlation coefficients within the same age groups.
| Age group | Sex | N | Correlation coefficient |
|
| Male | 4 | 0.87±0.02 |
| Female | 4 | 0.93±0.03 | |
| Male and Female | 8 | 0.87±0.04 | |
|
| Male | 4 | 0.93±0.03 |
| Female | 4 | 0.88±0.04 | |
| Male and Female | 8 | 0.90±0.04 | |
|
| Male | 4 | 0.98±0.01 |
| Female | 4 | 0.98±0.00 | |
| Male and Female | 8 | 0.98±0.01 | |
|
| Male | 3 | 0.96±0.02 |
| Female | 4 | 0.94±0.05 | |
| Male and Female | 7 | 0.95±0.03 |
Average correlation coefficients calculated within the groups of males, groups of females, groups of males and females of the same age. Values are means±SD.
Summary of age-related correlation coefficients between different age groups.
| Age group | Sex | Correlation coefficient |
|
| Male and Female | 0.73±0.07 |
|
| Male and Female | 0.63±0.07 |
|
| Male and Female | 0.61±0.10 |
|
| Male and Female | 0.89±0.06 |
|
| Male and Female | 0.87±0.07 |
|
| Male and Female | 0.95±0.02 |
Values are means±SD.
Genes classified into 16 categories according to the status of age-related expression.
| Category | Fetal stage | 12 weeks | 20 weeks | 30 weeks | Number of genes | Definition |
| 1 | 1 | 1 | 1 | 1 | 6763 | genes expressed from fetal stage to 30 weeks |
| 2 | 0 | 1 | 1 | 1 | 7564 | genes expressed from 12 to 30 weeks |
| 3 | 1 | 0 | 1 | 1 | 49 | |
| 4 | 0 | 0 | 1 | 1 | 3547 | genes expressed from 20 to 30 weeks |
| 5 | 1 | 1 | 0 | 1 | 14 | |
| 6 | 0 | 1 | 0 | 1 | 80 | |
| 7 | 1 | 0 | 0 | 1 | 7 | |
| 8 | 0 | 0 | 0 | 1 | 827 | genes expressed at 30 weeks |
| 9 | 1 | 1 | 1 | 0 | 73 | |
| 10 | 0 | 1 | 1 | 0 | 124 | |
| 11 | 1 | 0 | 1 | 0 | 29 | |
| 12 | 0 | 0 | 1 | 0 | 428 | genes expressed at 20 weeks |
| 13 | 1 | 1 | 0 | 0 | 16 | |
| 14 | 0 | 1 | 0 | 0 | 147 | genes expressed at 12 weeks |
| 15 | 1 | 0 | 0 | 0 | 84 | genes expressed in fetal stage |
| 16 | 0 | 0 | 0 | 0 | 23851 | genes not expressed from fetal stage to 30 weeks |
Depending on the status of expression, all spots on the microarray can be divided into 16 categories. Here, “1” represents an expressed gene and “0” represents an unexpressed gene.
Figure 3Ratios of categories for groups of the same age.
The ratios of the genes in each category were calculated for groups in the fetal stage and at 12, 20, and 30 weeks of age. Categories are defined in Table 5.
Age-related correlation coefficients for each gene set by classification.
| n | All spots | Category 1 | Category 2 | Category 4 | Category 8 | ||
|
| 43603 | 6763 | 7564 | 3547 | 827 | ||
|
| Fetal stage | 8 | 0.87±0.04 | 0.88±0.04 | - | - | - |
| 12 weeks | 8 | 0.90±0.04 | 0.89±0.05 | 0.77±0.10 | - | - | |
| 20 weeks | 8 | 0.98±0.01 | 0.98±0.01 | 0.96±0.01 | 0.80±0.04 | - | |
| 30 weeks | 7 | 0.95±0.03 | 0.94±0.03 | 0.92±0.04 | 0.72±0.11 | 0.29±0.21 |
Number of genes and correlation coefficients in each category. The average correlation coefficients were calculated between individuals for all spots and gene sets for Categories 1, 2, 4, and 8 within the same age group.
Figure 4Proportion of genes, by category, for genes with specific GO terms relating to biological processes.
(A) Category 1. (B) Category 2. The ratio of the genes in each category was calculated for selected GO terms. Categories are defined in Table 5.
Predominant genes with GO terms related to biological processes in category 1.
| Accession | Number of genes | GO term |
| GO:0000070 | 23 | mitotic sister chromatid segregation |
| GO:0007018 | 24 | microtubule-based movement |
| GO:0035046 | 22 | pronuclear migration |
| GO:0043161 | 29 | proteasomal ubiquitin-dependent protein catabolic process |
| GO:0051085 | 21 | chaperone mediated protein folding requiring cofactor |
| GO:0000022 | 54 | mitotic spindle elongation |
| GO:0030437 | 23 | ascospore formation |
| GO:0007052 | 73 | mitotic spindle organization |
| GO:0006818 | 32 | hydrogen transport |
| GO:0045059 | 20 | positive thymic T cell selection |
| GO:0042254 | 40 | ribosome biogenesis |
| GO:0006120 | 29 | mitochondrial electron transport, NADH to ubiquinone |
| GO:0007100 | 20 | mitotic centrosome separation |
| GO:0006412 | 253 | Translation |
| GO:0019886 | 43 | antigen processing and presentation of exogenous peptide antigen via MHC class II |
GO terms and the number of genes in the Agilent porcine microarray for each Accession are shown in Figure 4A.
Predominant genes with GO terms related to biological processes in category 2.
| Accession | Number of genes | GO term |
| GO:0016055 | 37 | Wnt receptor signaling pathway |
| GO:0006968 | 42 | cellular defense response |
| GO:0042742 | 46 | defense response to bacterium |
| GO:0051092 | 26 | positive regulation of NF-kappaB transcription factor activity |
| GO:0030318 | 24 | melanocyte differentiation |
| GO:0045664 | 22 | regulation of neuron differentiation |
| GO:0006605 | 35 | protein targeting |
| GO:0035116 | 35 | embryonic hindlimb morphogenesis |
| GO:0007159 | 36 | leukocyte cell-cell adhesion |
| GO:0035115 | 33 | embryonic forelimb morphogenesis |
| GO:0030217 | 21 | T cell differentiation |
| GO:0009725 | 24 | response to hormone stimulus |
| GO:0050767 | 31 | regulation of neurogenesis |
| GO:0042981 | 56 | regulation of apoptosis |
| GO:0006094 | 22 | Gluconeogenesis |
GO terms and the number of genes in the Agilent porcine microarray for each Accession are shown in Figure 4B.
Age effect on correlation coefficients for GO term biological processes.
| n | Spots with GO term | Neutrophil | Monocyte | platelet | Metabolic processes | ||
|
| 6019 | 57 | 50 | 36 | 1020 | ||
|
| Fetal stage | 8 | 0.90±0.04 | 0.95±0.03 | 0.92±0.06 | 0.96±0.02 | 0.89±0.05 |
| 12 weeks | 8 | 0.93±0.03 | 0.93±0.03 | 0.92±0.04 | 0.94±0.04 | 0.93±0.03 | |
| 20 weeks | 8 | 0.99±0.01 | 0.98±0.01 | 0.98±0.01 | 0.99±0.01 | 0.98±0.01 | |
| 30 weeks | 7 | 0.96±0.02 | 0.97±0.02 | 0.95±0.03 | 0.97±0.02 | 0.96±0.02 |
Given in the above table are predominant biological processes defined by Gene Ontology.
GO terms for a subset of GO:0002376 immune system processes.
| Number of genes in each category | |||||||
| Accession | All spots | Category1 | Category2 | Category4 | Category8 | Category16 | GO term |
| GO:0001776 | 10 | 1 | 5 | 1 | 2 | 1 | leukocyte homeostasis |
| GO:0002200 | 9 | 0 | 2 | 0 | 0 | 5 | somatic diversification of immune receptors |
| GO:0002252 | 60 | 15 | 16 | 3 | 0 | 22 | immune effector process |
| GO:0002253 | 62 | 23 | 25 | 5 | 2 | 31 | activation of immune response |
| GO:0002507 | 1 | 0 | 1 | 0 | 0 | 0 | tolerance induction |
| GO:0006955 | 356 | 102 | 63 | 18 | 6 | 102 | immune response |
| GO:0019882 | 140 | 31 | 11 | 3 | 1 | 15 | antigen processing and presentation |
| GO:0031294 | 4 | 0 | 2 | 0 | 0 | 1 | Lymphocyte costimulation |
| GO:0045058 | 44 | 22 | 7 | 3 | 0 | 9 | T cell selection |
| GO:0045321 | 125 | 21 | 29 | 4 | 4 | 34 | leukocyte activation |
| GO:0050900 | 76 | 23 | 18 | 1 | 0 | 23 | leukocyte migration |
The number of genes in selected categories was counted for each GO term. The GO term and the number of genes in the Agilent porcine microarray are also shown in the table. Categories are defined in Table 5.
Figure 5Signal intensity of major histocompatibility complex (MHC) genes.
(A) Swine leukocyte antigens (SLA) classical class I genes. (B) Swine leukocyte antigens (SLA) classical class II genes. (C) Interferon receptor genes. (D) Toll-like receptor (TLR) genes. Signal intensities were normalized using quantile normalization and log-transformed after excluded signals flagged as “absent.” The category numbers are shown in graph legends. Genes in Categories 1, 2, and 4 are shown in the graph.